| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 11.040 | 67.102 | 87.477 | 90.103 |
| Total Income - EUR | - | - | - | - | - | - | 11.040 | 67.102 | 87.549 | 90.152 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.227 | 22.546 | 41.381 | 37.211 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 8.813 | 44.556 | 46.168 | 52.940 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 8.703 | 43.899 | 45.307 | 51.544 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Proiris Medical Start S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 70.035 | 66.010 |
| Current Assets | - | - | - | - | - | - | 11.400 | 10.499 | 20.977 | 21.061 |
| Inventories | - | - | - | - | - | - | 3.063 | 6.084 | 5.934 | 8.031 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 3.668 | 10.064 |
| Cash | - | - | - | - | - | - | 8.337 | 4.415 | 11.375 | 2.966 |
| Shareholders Funds | - | - | - | - | - | - | 8.743 | 5.653 | 48.905 | 67.399 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.657 | 4.846 | 42.106 | 20.516 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Proiris Medical Start S.r.l.